SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARIAD Pharmaceuticals
ARIA 23.990.0%Feb 17 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike McFarland who wrote (573)6/19/1999 10:49:00 PM
From: John Dwyer  Read Replies (2) of 4474
 
Hi Mike,
I wasn't clear where you were headed with this
idea but if you are looking for a cancer link
with the SH3 domain and sos, check out Sugen's
pipeline (grb2 inhibs). Ariad was working on
grb2 as well but Sugen's patent that issued a
couple years ago took the wind out of Ariad's
cancer program.

With regard to the reports from SmallCaps, it's real
nice to see some fresh coverage on these
smallcap biotechs. I realize that the bulge-bracket
investment banks can't afford to cover such smallfry
but there is a critical need for this type of
analysis.

John
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News